| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | amyloid-beta binding | 3.63e-04 | 102 | 66 | 4 | GO:0001540 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 3.82e-04 | 9 | 66 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 3.82e-04 | 9 | 66 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | cytidine deaminase activity | 8.20e-04 | 13 | 66 | 2 | GO:0004126 | |
| GeneOntologyMolecularFunction | calcium channel activity | 8.79e-04 | 129 | 66 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | MHC protein binding | 9.35e-04 | 58 | 66 | 3 | GO:0042287 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 9.54e-04 | 14 | 66 | 2 | GO:0008331 | |
| GeneOntologyCellularComponent | Golgi membrane | RNF121 AP1S1 MARCHF8 ARFGEF2 AP1S2 ST3GAL3 RNF175 TMCO1 DOP1B | 4.19e-04 | 721 | 66 | 9 | GO:0000139 |
| GeneOntologyCellularComponent | lysosomal membrane | 6.23e-04 | 462 | 66 | 7 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 6.23e-04 | 462 | 66 | 7 | GO:0098852 | |
| GeneOntologyCellularComponent | AP-1 adaptor complex | 6.35e-04 | 12 | 66 | 2 | GO:0030121 | |
| GeneOntologyCellularComponent | vacuolar membrane | 1.07e-03 | 507 | 66 | 7 | GO:0005774 | |
| Domain | VDCC_a1su_IQ | 2.55e-04 | 7 | 66 | 2 | IPR014873 | |
| Domain | GPHH | 2.55e-04 | 7 | 66 | 2 | PF16905 | |
| Domain | GPHH_dom | 2.55e-04 | 7 | 66 | 2 | IPR031649 | |
| Domain | Ca_chan_IQ | 2.55e-04 | 7 | 66 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 2.55e-04 | 7 | 66 | 2 | PF08763 | |
| Domain | AP_complex_ssu | 2.55e-04 | 7 | 66 | 2 | IPR016635 | |
| Domain | MARCH-like | 3.40e-04 | 8 | 66 | 2 | IPR033275 | |
| Domain | CLAT_ADAPTOR_S | 4.36e-04 | 9 | 66 | 2 | PS00989 | |
| Domain | VDCCAlpha1 | 5.43e-04 | 10 | 66 | 2 | IPR002077 | |
| Domain | RINGv | 6.63e-04 | 11 | 66 | 2 | PF12906 | |
| Domain | ZF_RING_CH | 6.63e-04 | 11 | 66 | 2 | PS51292 | |
| Domain | APOBEC_N | 7.93e-04 | 12 | 66 | 2 | PF08210 | |
| Domain | Clathrin_sm-chain_CS | 7.93e-04 | 12 | 66 | 2 | IPR000804 | |
| Domain | APOBEC_N | 7.93e-04 | 12 | 66 | 2 | IPR013158 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 1.09e-03 | 14 | 66 | 2 | IPR016192 | |
| Domain | Znf_RING/FYVE/PHD | 1.15e-03 | 459 | 66 | 7 | IPR013083 | |
| Domain | AP_mu_sigma_su | 1.43e-03 | 16 | 66 | 2 | IPR022775 | |
| Domain | Clat_adaptor_s | 1.43e-03 | 16 | 66 | 2 | PF01217 | |
| Domain | Znf_RING-CH | 1.62e-03 | 17 | 66 | 2 | IPR011016 | |
| Domain | RINGv | 1.62e-03 | 17 | 66 | 2 | SM00744 | |
| Domain | Cytidine_deaminase-like | 1.62e-03 | 17 | 66 | 2 | IPR016193 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 1.62e-03 | 17 | 66 | 2 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 1.62e-03 | 17 | 66 | 2 | IPR002125 | |
| Domain | Ig_2 | 2.20e-03 | 73 | 66 | 3 | PF13895 | |
| Domain | IQ | 2.95e-03 | 81 | 66 | 3 | SM00015 | |
| Domain | TRYPSIN_SER | 3.98e-03 | 90 | 66 | 3 | IPR033116 | |
| Domain | IQ_motif_EF-hand-BS | 3.98e-03 | 90 | 66 | 3 | IPR000048 | |
| Domain | IQ | 4.36e-03 | 93 | 66 | 3 | PS50096 | |
| Domain | Longin-like_dom | 4.38e-03 | 28 | 66 | 2 | IPR011012 | |
| Domain | - | 5.02e-03 | 449 | 66 | 6 | 3.30.40.10 | |
| Domain | TRYPSIN_HIS | 5.80e-03 | 103 | 66 | 3 | IPR018114 | |
| Domain | Znf_RING | 5.89e-03 | 326 | 66 | 5 | IPR001841 | |
| Domain | TRYPSIN_SER | 6.27e-03 | 106 | 66 | 3 | PS00135 | |
| Domain | TRYPSIN_HIS | 6.44e-03 | 107 | 66 | 3 | PS00134 | |
| Domain | Peptidase_S1A | 7.48e-03 | 113 | 66 | 3 | IPR001314 | |
| Domain | TRYPSIN_DOM | 7.85e-03 | 115 | 66 | 3 | PS50240 | |
| Domain | zf-C3HC4 | 8.00e-03 | 223 | 66 | 4 | PF00097 | |
| Domain | Tryp_SPc | 8.23e-03 | 117 | 66 | 3 | SM00020 | |
| Domain | Trypsin | 9.02e-03 | 121 | 66 | 3 | PF00089 | |
| Domain | Trypsin_dom | 9.02e-03 | 121 | 66 | 3 | IPR001254 | |
| Domain | Peptidase_S1_PA | 9.43e-03 | 123 | 66 | 3 | IPR009003 | |
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 3.66e-06 | 2 | 67 | 2 | 23426690 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 23376566 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 38155373 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 21757542 | ||
| Pubmed | Critical roles for WDR72 in calcium transport and matrix protein removal during enamel maturation. | 3.66e-06 | 2 | 67 | 2 | 26247047 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 15050706 | ||
| Pubmed | Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging. | 1.10e-05 | 3 | 67 | 2 | 32641479 | |
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 1.10e-05 | 3 | 67 | 2 | 27602762 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 22691411 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 1.10e-05 | 3 | 67 | 2 | 22666481 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 27503069 | ||
| Pubmed | APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women. | 1.10e-05 | 3 | 67 | 2 | 24577894 | |
| Pubmed | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. | 1.10e-05 | 3 | 67 | 2 | 16648136 | |
| Pubmed | Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. | 1.10e-05 | 3 | 67 | 2 | 23533681 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 1541833 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 27356895 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 29466725 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 23315078 | ||
| Pubmed | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | 1.10e-05 | 3 | 67 | 2 | 25589647 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 23671100 | ||
| Pubmed | Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions. | 1.10e-05 | 3 | 67 | 2 | 31518043 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 23606747 | ||
| Pubmed | APOBEC3 signature mutations in chronic lymphocytic leukemia. | 1.10e-05 | 3 | 67 | 2 | 24840555 | |
| Pubmed | Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting. | 1.10e-05 | 3 | 67 | 2 | 24394417 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 9765497 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 24453360 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 23449789 | ||
| Pubmed | APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice. | 1.10e-05 | 3 | 67 | 2 | 18434399 | |
| Pubmed | Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection. | 1.10e-05 | 3 | 67 | 2 | 19153238 | |
| Pubmed | Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. | 1.10e-05 | 3 | 67 | 2 | 18772436 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 38299743 | ||
| Pubmed | Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. | 1.10e-05 | 3 | 67 | 2 | 18786991 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 286744 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 38996073 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 24725948 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 20702647 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 20980520 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 284359 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 20617165 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 31801862 | ||
| Pubmed | Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain. | 1.10e-05 | 3 | 67 | 2 | 39208378 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 31943071 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 23300075 | ||
| Pubmed | Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. | 1.10e-05 | 3 | 67 | 2 | 20566830 | |
| Pubmed | Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. | 1.10e-05 | 3 | 67 | 2 | 7884913 | |
| Pubmed | N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins. | 1.10e-05 | 3 | 67 | 2 | 25505062 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 31595054 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 1.10e-05 | 3 | 67 | 2 | 24523520 | |
| Pubmed | Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. | 1.10e-05 | 3 | 67 | 2 | 17967065 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 20335265 | ||
| Pubmed | Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor. | 1.10e-05 | 3 | 67 | 2 | 29593034 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 31830125 | ||
| Pubmed | Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. | 1.10e-05 | 3 | 67 | 2 | 21998583 | |
| Pubmed | Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels. | 1.10e-05 | 3 | 67 | 2 | 29208674 | |
| Pubmed | Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway. | 1.10e-05 | 3 | 67 | 2 | 38115583 | |
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 1.10e-05 | 3 | 67 | 2 | 26507659 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 2157836 | ||
| Pubmed | Distinctive High Expression of Antiretroviral APOBEC3 Protein in Mouse Germinal Center B Cells. | 1.10e-05 | 3 | 67 | 2 | 35458563 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 22275865 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 293683 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 19150103 | ||
| Pubmed | Initial sequencing and comparative analysis of the mouse genome. | 1.10e-05 | 3 | 67 | 2 | 12466850 | |
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 2.19e-05 | 4 | 67 | 2 | 32616470 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 26283199 | ||
| Pubmed | Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. | 2.19e-05 | 4 | 67 | 2 | 18983852 | |
| Pubmed | APOBEC3 regulates keratinocyte differentiation and expression of Notch3. | 2.19e-05 | 4 | 67 | 2 | 31400166 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 27503071 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 23725696 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 21985787 | ||
| Pubmed | APOBEC3A functions as a restriction factor of human papillomavirus. | 2.19e-05 | 4 | 67 | 2 | 25355878 | |
| Pubmed | Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms. | 2.19e-05 | 4 | 67 | 2 | 26253512 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 19117940 | ||
| Pubmed | Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains. | 2.19e-05 | 4 | 67 | 2 | 17020885 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 20375169 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 21147467 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 16055735 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 15728831 | ||
| Pubmed | The incorporation of APOBEC3 proteins into murine leukemia viruses. | 2.19e-05 | 4 | 67 | 2 | 18572219 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 16378963 | ||
| Pubmed | Multifaceted HIV-1 Vif interactions with human E3 ubiquitin ligase and APOBEC3s. | 2.19e-05 | 4 | 67 | 2 | 32893454 | |
| Pubmed | The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels. | 2.19e-05 | 4 | 67 | 2 | 25483588 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 2040623 | ||
| Pubmed | Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. | 2.19e-05 | 4 | 67 | 2 | 15269786 | |
| Pubmed | Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection. | 2.19e-05 | 4 | 67 | 2 | 24821801 | |
| Pubmed | Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G. | 2.19e-05 | 4 | 67 | 2 | 20363737 | |
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 2.19e-05 | 4 | 67 | 2 | 37141091 | |
| Pubmed | Expression and subcellular localisation of AID and APOBEC3 in adenoid and palatine tonsils. | 2.19e-05 | 4 | 67 | 2 | 29343743 | |
| Pubmed | APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. | 2.19e-05 | 4 | 67 | 2 | 15674295 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 21873525 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 31253182 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 27411398 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 25501566 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 18702815 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 20538015 | ||
| Pubmed | σ1B adaptin regulates adipogenesis by mediating the sorting of sortilin in adipose tissue. | 2.19e-05 | 4 | 67 | 2 | 24928897 | |
| Pubmed | The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance. | 2.19e-05 | 4 | 67 | 2 | 38049664 | |
| Pubmed | AP-1/sigma1B-adaptin mediates endosomal synaptic vesicle recycling, learning and memory. | 2.19e-05 | 4 | 67 | 2 | 20203623 | |
| Pubmed | Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection. | 2.19e-05 | 4 | 67 | 2 | 26846717 | |
| Pubmed | Vaccinia virus replication is not affected by APOBEC3 family members. | 2.19e-05 | 4 | 67 | 2 | 17052331 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 28415995 | ||
| Cytoband | 1q31 | 3.53e-04 | 19 | 67 | 2 | 1q31 | |
| GeneFamily | Ring finger proteins|Membrane associated ring-CH-type fingers | 3.74e-04 | 11 | 48 | 2 | 60 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 4.48e-04 | 12 | 48 | 2 | 406 | |
| GeneFamily | Kallikreins | 8.09e-04 | 16 | 48 | 2 | 616 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.15e-03 | 26 | 48 | 2 | 253 | |
| GeneFamily | WD repeat domain containing | 5.09e-03 | 262 | 48 | 4 | 362 | |
| GeneFamily | Ring finger proteins | 6.03e-03 | 275 | 48 | 4 | 58 | |
| GeneFamily | Proteases, serine | 1.22e-02 | 63 | 48 | 2 | 738 | |
| ToppCell | Control-Lymphocyte-B-Plasmablast|Control / Disease, Lineage and Cell Type | 4.59e-06 | 162 | 67 | 5 | 67b32c40cc180c5ebbfd901a417b5be469500110 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.75e-06 | 185 | 67 | 5 | 808d5e880069aff8866cd2c733b9fe568a37701f | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 192 | 67 | 5 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-05 | 194 | 67 | 5 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-05 | 194 | 67 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Nasal_Brush-Immune|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.10e-05 | 194 | 67 | 5 | 3135bc4a8112c5dee108e3b8e775f508b65191f1 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, condition lineage and cell class | 1.16e-05 | 196 | 67 | 5 | e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8 | |
| ToppCell | medial-Hematologic-Intermediate_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-05 | 198 | 67 | 5 | dbd7869483c5a67944cb94ced0ee2c7b999adc2e | |
| ToppCell | medial-Hematologic-Intermediate_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-05 | 198 | 67 | 5 | 8f64bb5cd8c3e2d5ef651821b0d59f67d1ca1a12 | |
| ToppCell | medial-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-05 | 198 | 67 | 5 | 432a26ace5b486695c9a933c0d44b73305b01ded | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-B-B_intermediate|Leuk-UTI / Disease, condition lineage and cell class | 1.24e-05 | 199 | 67 | 5 | e3edf3bcb381dbcf0092bdc2ee93ba852d32af3f | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.45e-05 | 158 | 67 | 4 | 9e0589f770920f8ac41cfe5cd0a29e9e7a04a308 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 9.68e-05 | 159 | 67 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-04 | 162 | 67 | 4 | 2d28306c6125b31f11ea6d911a167b93a74907c5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 166 | 67 | 4 | 63dc58864268b4e7779e4c45155022556fc634f9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 167 | 67 | 4 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.17e-04 | 167 | 67 | 4 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 169 | 67 | 4 | 4b3a7b4a497178799b6b2f0b744f5fb752cee31a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 169 | 67 | 4 | a4fd646b9bf87225131fca530bd6b52df9eaf489 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-04 | 170 | 67 | 4 | 3e52d40b0c36ab5b627a2dad025248901af8a320 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 170 | 67 | 4 | 12203d4410f38cc933d9f160b5fb76828df94119 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 170 | 67 | 4 | f9decb3bf3bf6d4996b0ac27af768236e116aac5 | |
| ToppCell | Monocytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.25e-04 | 170 | 67 | 4 | 4e93b66b3033e6e4d5f6d2f41974623a53108f5e | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-04 | 171 | 67 | 4 | b3e6e31dfe3623b960ccf692fdbd236fa4039923 | |
| ToppCell | Immune_cells-B_cell|Immune_cells / Lineage and Cell class | 1.31e-04 | 172 | 67 | 4 | b646894b691a99bf2742bd9da8e578dff0e87f1f | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 174 | 67 | 4 | 2f4bc0275cbcaa830d04a4c76e042456908d2277 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 174 | 67 | 4 | 01eff218e71a04201189a0313aaf91437fffed95 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.37e-04 | 174 | 67 | 4 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 174 | 67 | 4 | f0f6d135e1fb4c15022be103b00d8d5456515a18 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-04 | 174 | 67 | 4 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 175 | 67 | 4 | c36b4526970db9ccfbe2c70b00961fab9f13b133 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 175 | 67 | 4 | c1e082538f31b5c98ac63f71dcca4a1211a14708 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 175 | 67 | 4 | 2f9b5bdf8a62e8e99d1c4f677a8e5525bfd3b4ce | |
| ToppCell | Bronchial_Biopsy-Immune-Neutrophils|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.53e-04 | 179 | 67 | 4 | 8c50e13927c09de05c86cd90dd6f71cee004b0d3 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 180 | 67 | 4 | 243622eee35d38748e945677ff115616e763e3b4 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 180 | 67 | 4 | ce2fc270f9d9110c2544083f61936b0b7d3b7eb3 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 180 | 67 | 4 | 3a8d9a71efe113d1df3933902a625c0a56812074 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-04 | 181 | 67 | 4 | 3dcb74b28f93be35ddf4de1937f7e30b25e11927 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 181 | 67 | 4 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-04 | 181 | 67 | 4 | 7679a5980011d6dfb1aaca7abf678c29b6f819bb | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 182 | 67 | 4 | f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1 | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.66e-04 | 183 | 67 | 4 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | Nasal_Brush-Immune-Dendritic_cells|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.66e-04 | 183 | 67 | 4 | b1daec831990a53e846c089cebfcf4f8440820e4 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.70e-04 | 184 | 67 | 4 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 185 | 67 | 4 | eb338fcda0b237c2e0b9b4b0daf51febbfe1d79c | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 185 | 67 | 4 | c31bb53852caf36964b83b28bcaee07b679da779 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-04 | 186 | 67 | 4 | 39e475a3c167b33daa63b0c1bfa32451c5f46635 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 186 | 67 | 4 | 664295cd508dc3894d55da7e9d9cd75bf1432f52 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 186 | 67 | 4 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 186 | 67 | 4 | b30eb0c1673ca1ebc9b6248877d86fd6d6d14470 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-04 | 186 | 67 | 4 | 02418c50fdcca549bf73dedf6199ab4a27862a9b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-04 | 187 | 67 | 4 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 1.81e-04 | 187 | 67 | 4 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-04 | 187 | 67 | 4 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 187 | 67 | 4 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.84e-04 | 188 | 67 | 4 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.84e-04 | 188 | 67 | 4 | ecba5d06cbf3254448255a2aeefffe711f43310e | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.84e-04 | 188 | 67 | 4 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 188 | 67 | 4 | 1f07e3ab87173426fe0c429f5c084fb3425effd3 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 188 | 67 | 4 | 85746f95319e494efdc1bbc24331698688d3a900 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.84e-04 | 188 | 67 | 4 | ef05d2fb17fd427d46d454e67073e0e1b45bb24c | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.84e-04 | 188 | 67 | 4 | e5ab89030783461e9367ab87c353fb5c31911020 | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.84e-04 | 188 | 67 | 4 | 13653481d64c7a1ad833d738a3ee0bb9def7cec7 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.84e-04 | 188 | 67 | 4 | 8cf135da4d1d2500755d2809d60b41509af9fa8b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.88e-04 | 189 | 67 | 4 | ebaf722738c71d5f33f72341f801c6880f4aee14 | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.88e-04 | 189 | 67 | 4 | 659deb617a560bcde67c75f477d30ce85aaec3c6 | |
| ToppCell | facs-Heart-LV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 189 | 67 | 4 | d424d2554595b2304219f7324406b401711af7c2 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 189 | 67 | 4 | 393ec5954a12d6cf67bb435dcc34ff0b14c81e9f | |
| ToppCell | facs-Heart-LV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 189 | 67 | 4 | bec57459ad4bab15b2532b57722549fec2e771fb | |
| ToppCell | Monocytes-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.88e-04 | 189 | 67 | 4 | 22d08c7dde697f385100f72e009eeac8d19d329d | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.88e-04 | 189 | 67 | 4 | 67f9a9861d2dcc128b7a69432c6b31da185e2249 | |
| ToppCell | control-Myeloid-CD14_Monocytes_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.92e-04 | 190 | 67 | 4 | 47513757e0059e8370e49672a577f25ca842e98c | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.92e-04 | 190 | 67 | 4 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | IPF-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 1.92e-04 | 190 | 67 | 4 | f9c2a13c7f6460e3b348581be855b7281c8f70b5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-04 | 191 | 67 | 4 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.96e-04 | 191 | 67 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-04 | 191 | 67 | 4 | 5d6ef70cc15ec5e983a953e547e40f9c06e355fb | |
| ToppCell | Monocytes-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.96e-04 | 191 | 67 | 4 | ca0a5dc82cdef02e88fed937ca5784761896af33 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-04 | 191 | 67 | 4 | 1c7d31684654ca6a046d8cc816af1fdc42369c57 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-04 | 191 | 67 | 4 | d60d81d2045c6e624bbc8b17e13a32f7921d969f | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.00e-04 | 192 | 67 | 4 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 2.00e-04 | 192 | 67 | 4 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-04 | 192 | 67 | 4 | 5012cc3ec0766f06af447463413422b484446c43 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Granulocytic-Neutrophil|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-04 | 192 | 67 | 4 | e2fa1ba26d28953f0d35d95764b5dbe0b93a1191 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Granulocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-04 | 192 | 67 | 4 | 161f4626571b1bce5758fad1fe5ce41a4621771d | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 193 | 67 | 4 | cb0fb21510124883e716780bea46575620c366b8 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-04 | 193 | 67 | 4 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.04e-04 | 193 | 67 | 4 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-04 | 193 | 67 | 4 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | Monocytes|World / lung cells shred on cell class, cell subclass, sample id | 2.04e-04 | 193 | 67 | 4 | d66d3927f8fbe1544b5cfa5ee91a7f4a0ef1e810 | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 2.04e-04 | 193 | 67 | 4 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.04e-04 | 193 | 67 | 4 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 193 | 67 | 4 | 0c207879f994c227dcd1322faa69ec9e3749cdaa | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 193 | 67 | 4 | 1f978e102a029a6beb10913052cd0a20c7253e8e | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 193 | 67 | 4 | 0fbbfcc803edc3cd96b35467ad5cc573af07fd67 | |
| ToppCell | IPF-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 2.04e-04 | 193 | 67 | 4 | ef66a46e7ab44fcc4005a23416e6da478a4cce37 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-04 | 194 | 67 | 4 | f76808666fb875fc787751cbfd924d9be20a8192 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 194 | 67 | 4 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-04 | 194 | 67 | 4 | de9c7c602d886d0cd8bbd1d7e7744f84df951238 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-04 | 194 | 67 | 4 | 49441ca0a8fa34cb847fecbb4b809dd01d879ebb | |
| Drug | Ethotoin [86-35-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 1.49e-06 | 194 | 66 | 7 | 4366_UP | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 1.98e-05 | 192 | 66 | 6 | 4152_DN | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 2.23e-05 | 196 | 66 | 6 | 6813_DN | |
| Drug | Droperidol [548-73-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.29e-05 | 197 | 66 | 6 | 2645_UP | |
| Drug | Nabumetone [42924-53-8]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 2.36e-05 | 198 | 66 | 6 | 6487_UP | |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; PC3; HT_HG-U133A | 2.50e-05 | 200 | 66 | 6 | 5735_UP | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 1.48e-05 | 3 | 66 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 2.95e-05 | 4 | 66 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | nephrolithiasis | 5.56e-05 | 33 | 66 | 3 | EFO_0004253 | |
| Disease | Amelogenesis imperfecta type 2 | 7.35e-05 | 6 | 66 | 2 | cv:C0399372 | |
| Disease | Osteoporosis | 7.35e-05 | 6 | 66 | 2 | cv:C0029456 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.03e-04 | 7 | 66 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | autoantibody measurement | 1.03e-04 | 7 | 66 | 2 | EFO_0004866 | |
| Disease | Amelogenesis Imperfecta hypomaturation type | 1.37e-04 | 8 | 66 | 2 | C0399372 | |
| Disease | kallikrein-11 measurement | 1.76e-04 | 9 | 66 | 2 | EFO_0010573 | |
| Disease | Hypercalcemia | 3.78e-04 | 13 | 66 | 2 | C0020437 | |
| Disease | Milk-Alkali Syndrome | 3.78e-04 | 13 | 66 | 2 | C0026141 | |
| Disease | urolithiasis | 3.86e-04 | 63 | 66 | 3 | MONDO_0024647 | |
| Disease | blood urea nitrogen measurement | 5.23e-04 | 452 | 66 | 6 | EFO_0004741 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 6.56e-04 | 17 | 66 | 2 | EFO_0021969 | |
| Disease | Amelogenesis imperfecta | 6.56e-04 | 17 | 66 | 2 | cv:C0002452 | |
| Disease | citrate measurement | 7.49e-04 | 79 | 66 | 3 | EFO_0010114 | |
| Disease | FEV change measurement, response to zileuton | 1.43e-03 | 25 | 66 | 2 | EFO_0005921, EFO_0007676 | |
| Disease | Bone Diseases, Developmental | 1.67e-03 | 27 | 66 | 2 | C0005941 | |
| Disease | corpus callosum mid-anterior volume measurement | 1.67e-03 | 27 | 66 | 2 | EFO_0010297 | |
| Disease | body weight | 1.91e-03 | 1261 | 66 | 9 | EFO_0004338 | |
| Disease | chronic kidney disease | 1.92e-03 | 235 | 66 | 4 | EFO_0003884 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSIQRVAVWILEKYY | 266 | Q9ULK5 | |
| LLRIFKVTKYWASLR | 586 | O00555 | |
| KTYVSKKLTRYLNWI | 51 | O60825 | |
| KLTLWYYSEERKLVS | 976 | Q9BSJ8 | |
| SYTWLCYEVKIKRGR | 31 | Q96AK3 | |
| SYTWLCYEVKIKRGR | 31 | Q9UH17 | |
| TTRYKIYREFARWKV | 66 | O60477 | |
| AVFTEKQRLRWYYLL | 251 | P30988 | |
| RKFFLRIGVVYKIWI | 1756 | Q9Y6D5 | |
| EWRDLKVVYKRYASL | 51 | P61966 | |
| AVIQRCYRKYKQLTW | 1076 | O94983 | |
| EYYCRLDFLWKKKLR | 811 | Q8NFM4 | |
| FYVWKRVFQRYAILK | 356 | Q5I7T1 | |
| RLLRIFKVTKYWSSL | 581 | Q00975 | |
| DYASRYVLWKQIIER | 706 | Q86XH1 | |
| IRMIIAVTSYKRYLW | 1381 | Q8IZT6 | |
| KYVYVGLKDRSILVW | 1446 | Q149M9 | |
| WRLDRKLGVYVLVLY | 581 | Q8NFF2 | |
| VSRYVLWIRETIRKY | 251 | Q9UKR3 | |
| CSFLEWRDLKIVYKR | 46 | P56377 | |
| WRDLKIVYKRYASLY | 51 | P56377 | |
| LLLEYWKRKSATLAY | 436 | Q6IWH7 | |
| LEYFVRYLKLLQKDW | 521 | Q8NG48 | |
| LAFCWIYVRKYQSRR | 26 | Q9NUN5 | |
| YAYTKRAWRKEVLEL | 1961 | Q9Y3R5 | |
| EALVDFIYQYWKLKR | 421 | Q9NQC1 | |
| WDLLYKLRFVLTYIA | 1236 | Q9H6A9 | |
| LIISCRKLFYFKIWA | 361 | Q8N4B4 | |
| LRWLQLYIYKDREVT | 126 | Q9UJM8 | |
| VERKIYKAYKWLRYS | 656 | Q96JK2 | |
| VYVQLWKRLKAYNRV | 221 | Q5T0T0 | |
| RWKKRYFKLRGRTLY | 81 | Q86XP1 | |
| YVQCKVYVQLWRRLK | 216 | Q8TCQ1 | |
| KYIWRLCVARHKFYR | 291 | Q16825 | |
| KKRLWEKRYYCHSEV | 836 | O00750 | |
| KRTAKYRWFAVLYLL | 506 | Q06495 | |
| TRAIIKCYWKSYLVL | 81 | O15439 | |
| EIVIREYHKWRTYFK | 216 | Q9HAP2 | |
| YVKRTWYRKFVGVVL | 1786 | Q4ZHG4 | |
| VYTNICRYLDWIKKI | 241 | O60259 | |
| SWKKLYVCLRRSGLY | 306 | Q13322 | |
| LWVLIAYILYRKKIF | 646 | Q68CP4 | |
| VLRCRGWYDKVVYKL | 121 | Q6BAA4 | |
| GLWYCYLQVKKVRLR | 6 | Q5T0J3 | |
| LWIRYSQYLDRQLKV | 346 | Q15020 | |
| YKIFKIDIVLWYRDS | 356 | P14778 | |
| DCRYVSWRRKKLYLL | 206 | Q9HBV1 | |
| ILCYRKREWIKETFY | 856 | P42702 | |
| RWSRISRAKKLYKIY | 76 | O14921 | |
| KTQKRAALYTWYVRK | 161 | P35680 | |
| AALYTWYVRKQREIL | 166 | P35680 | |
| CIELWLQYTQKRRYK | 456 | A8K8P3 | |
| ITWVLVYRTDKYKRL | 76 | Q9UM00 | |
| LLWRKVYYEVIQLIK | 81 | Q9UPR3 | |
| QEYRLYREKKTALWI | 56 | Q8NHL6 | |
| RLKICYFMRYWILKF | 71 | Q8IV61 | |
| FKWLKYIVYKERVSA | 236 | Q11203 | |
| KLVKEEVFWRNYFYR | 191 | Q96A49 | |
| ISKYRVRIRSKKWYS | 746 | Q96JS3 | |
| VRIRSKKWYSILVSY | 751 | Q96JS3 | |
| VYTRVTKYRDWIASK | 421 | Q6ZWK6 | |
| RTPRLVYKWFLLIYK | 131 | Q8N4F7 | |
| RLLLVVFSKCWKVYD | 226 | Q3MJ13 | |
| VEKIIRTRIYESKYW | 21 | Q8NAV1 | |
| RTRIYESKYWKEECF | 26 | Q8NAV1 | |
| TPRLVYKWFLLIYKI | 131 | Q9H920 | |
| VDTYIYIWDIKDTRK | 126 | Q6PJI9 | |
| IFTYERKWYSRKDLA | 156 | Q86UK7 | |
| KLVADFQRYILYWRK | 91 | Q9NRM2 | |
| YSTIDWNKLYRREIK | 321 | Q15418 | |
| VFEKTRWIIEKYRLS | 741 | Q5VVJ2 |